Yubo International Biotech Limited
YBGJ
$0.01
$0.01120.41%
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -11.77% | 42.86% | |||
| Depreciation & Amortization | -96.56% | -34.46% | |||
| Other Operating Expenses | 8.96% | -57.77% | |||
| Total Operating Expenses | -17.42% | -2.85% | |||
| Operating Income | 17.42% | -1.33% | |||
| Income Before Tax | 8.92% | -3.26% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 8.92% | -3.26% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -7.14% | -7.44% | |||
| Net Income | 9.06% | -4.28% | |||
| EBIT | 17.42% | -1.33% | |||
| EBITDA | 8.57% | -7.97% | |||
| EPS Basic | 6.25% | -6.67% | |||
| Normalized Basic EPS | 10.00% | -11.11% | |||
| EPS Diluted | 6.25% | -6.67% | |||
| Normalized Diluted EPS | 10.00% | -11.11% | |||
| Average Basic Shares Outstanding | 0.00% | -0.20% | |||
| Average Diluted Shares Outstanding | 0.00% | -0.20% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||